Single- and multiple-dose kinetics of intravenous digoxin
- PMID: 7408393
- DOI: 10.1038/clpt.1980.171
Single- and multiple-dose kinetics of intravenous digoxin
Abstract
Nine healthy men received 0.5, 1.0, and 1.5 mg digoxin intravenously in random sequence on occasions separated by at least 4 wk. Digoxin concentrations were measured in serum samples drawn during 36 hr after each dose, and a mean across-dose kinetic profile was determined for each subject. After a 6-mo washout period, the same subjects received 0.25 mg digoxin intravenously every 24 hr for 10 consecutive days. Samples were drawn every 12 hr during the first 9 days and at multiple points during 72 hr after the last dose. Mean kinetic variables for the single- and multiple-dose trials were as follows: elimination half-life (t1/2), 27.9 and 38.0 hr (r = 0.62); volume of distribution, 5.5 and 7.4 l/kg (r = -0.56); total clearance, 2.50 and 2.49 ml/min/kg (r = 0.19); urinary excretion t1/2, 40.9 and 37.9 hr (r = -0.14). Mean observed and predicted predose steady-state serum concentrations were 0.59 and 0.79 ng/ml (r = -0.02). Mean values of accumulation and elimination t1/2 were nearly identical (27.8 and 27.9 hr), but were not positively correlated (r = -0.64). Multiple-dose digoxin therapy leads to no systematic change in digoxin clearance. Single-dose kinetics is poorly predictive of the rate and extent of drug accumulation and of washout kinetics during and after multiple-dose therapy.
Similar articles
-
Dose-independent pharmacokinetics of digoxin in humans.Am Heart J. 1978 Oct;96(4):507-11. doi: 10.1016/0002-8703(78)90162-x. Am Heart J. 1978. PMID: 358815 Clinical Trial.
-
Acceleration of digoxin clearance by activated charcoal.Clin Pharmacol Ther. 1985 Apr;37(4):367-71. doi: 10.1038/clpt.1985.55. Clin Pharmacol Ther. 1985. PMID: 3978996 Clinical Trial.
-
Impairment of digoxin clearance by coadministration of quinidine.J Clin Pharmacol. 1981 Oct;21(10):396-400. doi: 10.1002/j.1552-4604.1981.tb01739.x. J Clin Pharmacol. 1981. PMID: 7309901
-
Digoxin pharmacokinetics and dosage requirements in pediatric patients.Clin Pharm. 1983 May-Jun;2(3):224-35. Clin Pharm. 1983. PMID: 6349908 Review.
-
Clinical pharmacokinetics of amiodarone.Clin Pharmacokinet. 1984 Mar-Apr;9(2):136-56. doi: 10.2165/00003088-198409020-00002. Clin Pharmacokinet. 1984. PMID: 6370540 Review.
Cited by
-
The quinidine-digoxin interaction in perspective.Clin Pharmacokinet. 1983 Mar-Apr;8(2):137-54. doi: 10.2165/00003088-198308020-00002. Clin Pharmacokinet. 1983. PMID: 6303672 Review. No abstract available.
-
Pharmacokinetics of drugs in obesity.Clin Pharmacokinet. 1982 Mar-Apr;7(2):108-24. doi: 10.2165/00003088-198207020-00002. Clin Pharmacokinet. 1982. PMID: 7039924 Review.
-
Digitoxin accumulation.Br J Clin Pharmacol. 1982 Aug;14(2):225-9. doi: 10.1111/j.1365-2125.1982.tb01966.x. Br J Clin Pharmacol. 1982. PMID: 7104174 Free PMC article.
-
Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.Br J Clin Pharmacol. 1991 Nov;32(5):569-72. doi: 10.1111/j.1365-2125.1991.tb03953.x. Br J Clin Pharmacol. 1991. PMID: 1954072 Free PMC article. Clinical Trial.
-
Kinetics of the translactal passage of digoxin from breast feeding mothers to their infants.Eur J Pediatr. 1982 Feb;138(1):49-52. doi: 10.1007/BF00442328. Eur J Pediatr. 1982. PMID: 7075628
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources